Edit
The Epitranscriptome – Course and Conference Office

EMBL Conference

The Epitranscriptome

Overview

Registration is not yet open for this event. If you are interested in receiving more information please register your interest.

Conference Overview

The regulation of the transcriptome is key to cellular processes that underpin cell biology, development and tissue function. All classes of cellular RNA are subject to post-transcriptional modification, be it by direct chemical modification, editing or non-templated nucleotide additions. It is now emerging that the modification status of the transcriptome is dynamic and responsive to environmental/developmental cues. Together, this has elicited the realisation of an ‘epitranscriptome’ where post-transcriptional RNA modification coupled with recruitment of effector RNA binding proteins dynamically regulates genomic output. Importantly, mutations in setting or reading RNA modifications are causative of many human diseases or congenital disorders. This meeting aims to explore all aspects of this emerging topic, from methods development to molecular mechanism. Most importantly, the meeting will place an emphasis on the contribution of RNA modification to mammalian development, tissue homeostasis and disease.

Session Topics

  • RNA modification I (m6A)
  • RNA modifications in stem cells and development
  • RNA modification II (m5C, m1A, 3’ terminal additions, etc)
  • RNA modification pathways in physiology and pathology
  • Emerging concepts

What past participants say about the conference:

“The Epitranscriptome EMBL conference rapidly became a must in the field.” – Mattia Pelizzola, Istituto Italiano di Tecnologia, Italy.

“The conference provided an excellent opportunity to get the latest insights in the field of epitranscriptomics, presented by the world-leading academic groups.” – Gerhard Müller, Gotham Therapeutics, New York, USA.

“This conference was really good for me. I have learnt about new RNA regulatory mechanisms, especially m6A and how it’s an important target for RNA processing.” – Opeyemi Olotu, University of Turku, Finland.

Sponsors

Sponsorship Opportunities

We offer a variety of event sponsoring possibilities, with the flexibility to select a set sponsorship package or combine individual sponsorship options to suit your event budget. Discounts are available for companies sponsoring multiple events at EMBL Heidelberg. View other conferences, or contact sponsorship@embl.de for further information.

If you are interested in becoming a media partner of this event, please visit our media partnerships webpage.

Date: 9 - 11 Feb 2022

Location: EMBL Heidelberg

Organisers:

  • Michaela Frye
    German Cancer Research Centre, Germany

EMBL Courses and Conferences are kindly supported by our Corporate Partnership Programme

Founder partners

Corporate partners

Associate partners

Edit